http://www.fpnotebook.com/
Pregabalin
Aka: Pregabalin, Lyrica
- Indications
- Anticonvulsant
- Adjunct for partial-onset Seizures
- Neuropathic Pain Management
- Fibromyalgia
- Peripheral Neuropathy
- Diabetic Peripheral Neuropathy
- Postherpetic Neuralgia
- Mechanism
- Alpha2-delta1 Ligand agent
- Binds alpha2-delta1 subunit of Central Nervous System voltage-gated calcium channels
- Does not bind GABA receptors or Benzodiazepine receptors
- Adverse effects
- Common adverse effects
- Weight gain
- Peripheral edema
- Dizziness or ataxia
- Somnolence
- Headache
- Xerostomia
- Tremor
- Blurred vision or Diplopia
- Severe but uncommon adverse effects
- Angioedema
- Hypersensitivity Reaction
- Rhabdomyolysis (rare)
- Dosing
- Starting: 25 mg orally three times daily (starting low dose maximizes tolerability)
- Titrate to effective dose in increments on weekly basis based on tolerability
- Maximum dose: 450 mg/day divided 2-3 times daily
- Fibromyalgia may require the maximum dose
- Stopping: Taper off agent (Do not stop abruptly due to withdrawal symptoms)